Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 2:00 AM ET

Date/Time Source News Release
12/30/2024 07:30 AM EST PR Newswire NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Filing of F-4 Registration Statement with the SEC Ahead of Proposed Merger
12/19/2024 07:30 AM EST ACCESSWIRE NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND Meeting for an Innovative Breakthrough Type 1 Diabetes Treatment
12/11/2024 07:30 AM EST ACCESSWIRE NLS Pharmaceutics CEO Issues Letter to Shareholders
12/04/2024 01:15 PM EST PR Newswire NLS Pharmaceutics Ltd. Announces Pricing of Private Placement of up to $1 Million at a 15% Premium to the Market
12/03/2024 07:40 AM EST ACCESSWIRE NLS Pharmaceutics Announces Promising Preclinical Data for First-in-Class Non-Sulfonamide, Dual Orexin Receptor Agonists for the Potential Treatment of Narcolepsy and Neurological Disorders
11/18/2024 07:30 AM EST ACCESSWIRE NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
11/04/2024 07:00 AM EST ACCESSWIRE NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement
10/21/2024 07:00 AM EDT ACCESSWIRE NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence
10/15/2024 07:00 AM EDT ACCESSWIRE NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
09/25/2024 08:00 AM EDT ACCESSWIRE NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
Page

Additional News

As of January 4, 2025 • 2:00 AM ET

Date/Time Source News Release
12/30/2024 11:01 AM EST 24/7 Market News Nearly There
12/10/2024 01:33 PM EST SeekingAlpha Which subsectors to own and which to avoid - Wolfe Research
12/04/2024 02:13 PM EST SeekingAlpha NLS Pharmaceutics announces pricing of private placement of up to $1M
11/04/2024 08:01 AM EST 24/7 Market News NLS Pharmaceutics to Merge with Kadimastem
11/04/2024 07:44 AM EST SeekingAlpha NLS Pharmaceutics stock rallies 48% on merger agreement with cell therapy developer Kadimastem
10/28/2024 07:16 AM EDT SeekingAlpha NLS Pharmaceutics regains compliance with Nasdaq
10/28/2024 07:00 AM EDT ACCESSWIRE IA NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
09/27/2024 09:01 AM EDT KlickAnalytics NLSP announced stock split 1-40
09/25/2024 08:17 AM EDT SeekingAlpha NLS Pharmaceutics to conduct reverse share split
07/30/2024 06:58 AM EDT PennyStocks.com Penny Stocks Trading Strategies For Different Market Conditions
Page